4//SEC Filing
Pay Paul William 4
Accession 0001778480-19-000002
CIK 0001540159other
Filed
Jun 10, 8:00 PM ET
Accepted
Jun 11, 7:07 PM ET
Size
6.0 KB
Accession
0001778480-19-000002
Insider Transaction Report
Form 4
Pay Paul William
Director
Transactions
- Award
Stock Option (right to buy)
2019-06-07+30,579→ 30,579 totalExercise: $0.38Exp: 2027-09-26→ Common Shares (30,579 underlying)
Footnotes (4)
- [F1]On June 7, 2019, Edesa Biotech, Inc. (formerly known as Stellar Biotechnologies, Inc.) completed its share exchange transaction with Edesa Biotech Inc. ("Edesa") and the shareholder of Edesa pursuant to that certain Share Exchange Agreement, dated March 7, 2019. This option was issued in replacement of an option to purchase shares of Edesa.
- [F2]All share numbers and exercise prices reflect the 1-for-6 reverse split of the Issuer's common shares which occurred on June 7, 2019.
- [F3]This option vests and becomes exercisable 1/3 on 9/26/18, and monthly thereafter through 9/26/20.
- [F4]In Canadian currency.
Documents
Issuer
Edesa Biotech, Inc.
CIK 0001540159
Entity typeother
Related Parties
1- filerCIK 0001778480
Filing Metadata
- Form type
- 4
- Filed
- Jun 10, 8:00 PM ET
- Accepted
- Jun 11, 7:07 PM ET
- Size
- 6.0 KB